1 year return (CAGR)
49.66%
Emcure Pharmaceuticals Ltd Exchange (NSE, INR)
EMCURE.NSE
-
+30.60 (+2.10%)
HealthcareDrug Manufacturers - Specialty & Generic
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
282.22B
Price/Sales
3.22
Ent value
-
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-
Trailing P/E
32.44
PEG
-
Forward P/E
24.53
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 1468.00 |
| Daily high | 1495.00 |
| Daily low | 1442.80 |
| Daily Volume | 208K |
| 1y analyst estimate | 1794.83 |
| Beta | - |
| EPS (TTM) | 45.88 |
| Dividend per share | 0.00 |
| Ex-div date | 14 Aug 2025 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| EMCURE.NSE | S&P500 | |
| Current price drop from All-time high | -5.21% | -1.98% |
| Highest price drop | -40.68% | -56.47% |
| Date of highest drop | 9 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -12.39% | -10.67% |
| Avg time to new high | 24 days | 12 days |
| Max time to new high | 328 days | 1805 days |
News
No items found